← Back to Search

Plant-Based Diet for Breast Cancer

N/A
Waitlist Available
Led By Thomas M Campbell, MD
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women with a confirmed diagnosis of metastatic breast cancer with a stable treatment regimen, demonstrated by no changes in primary cancer therapy 6 weeks prior to consent and no anticipated changes in primary cancer therapy in the 4 weeks following consent.
Systemic therapy may consist of any conventional treatment including anti-hormonal, cytotoxic, targeted monoclonal antibody or small molecule kinase inhibitors or any combination of the above. Women who have previously declined conventional cancer therapy are also eligible provided they meet all other eligibility criteria.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will study whether a plant-based diet can improve the health of women with metastatic breast cancer.

Eligible Conditions
  • Breast Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Compliance
Recruitment
Retention
Secondary outcome measures
Blood Pressure
Brief Fatigue Inventory (BFI)
Changes in nutrient intakes based on 3 day food diaries
+13 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Subjects are provided three meals daily, attend weekly office visits, take a daily multivitamin.
Group II: Control GroupActive Control1 Intervention
Women instructed to maintain current intake and take a provided multivitamin.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Plant-Based Diet
2019
N/A
~240

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
833 Previous Clinical Trials
518,112 Total Patients Enrolled
12 Trials studying Breast Cancer
1,713 Patients Enrolled for Breast Cancer
Johns Hopkins UniversityOTHER
2,242 Previous Clinical Trials
14,816,605 Total Patients Enrolled
27 Trials studying Breast Cancer
23,448 Patients Enrolled for Breast Cancer
Thomas M Campbell, MD3.911 ReviewsPrincipal Investigator - University of Rochester
University of Rochester
1 Previous Clinical Trials
15 Total Patients Enrolled
5Patient Review
Dr. Campbell is an excellent physician who is not only knowledgeable and up-to-date, but also caring. His bedside manner is excellent, and he is a great listener. I would highly recommend him to anyone.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Mar 2025